← Open Payments lookup

GREGORY MATTINGLY: Open Payments

NPI 1215933379 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,012,688 in 883 payments from 28 companies in 2025. Trend: 2023 $857,163 · 2024 $842,175 · 2025 $1,012,688

Speaker / faculty: $458,191Honoraria: $253,228Consulting: $155,418Travel & lodging: $123,005Food & beverage: $17,561Speaker / faculty: $5,225
CompanyPaymentsAmount
Axsome Therapeutics, Inc.123$172,023
Neurocrine BioSciences, Inc.101$130,424
ABBVIE INC.113$120,029
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)86$99,639
Otsuka America Pharmaceutical, Inc.107$96,398
Supernus Pharmaceuticals, Inc.80$87,294
E.R. Squibb & Sons, L.L.C.70$84,047
Alkermes, Inc.39$47,703
H. Lundbeck A S10$40,313
Janssen Pharmaceuticals, Inc29$33,152

Products named: Auvelity, INGREZZA, CAPLYTA, VRAYLAR, REXULTI, Qelbree, COBENFY, SPRAVATO.

Industry payments across MO — which companies pay providers there.